2021 ASM Guidelines
In 2021, the American Society for Microbiology (ASM) released new guidelines for detecting and identifying GBS for prevention of disease in newborns. ASM’s guidelines replace the 2010 guidelines published by CDC.
Domestically, CDC’s Streptococcus Laboratory supports the national population-based Active Bacterial Core surveillance through
- Serotyping of S. agalactiae (GBS) isolates
- Antimicrobial susceptibility testing
- Strain characterization by whole genome sequencing
The lab supports training and development of improved strain surveillance methods.